Adiponectin gene polymorphism (G276T) is not associated with incipient diabetic nephropathy in Japanese type 2 diabetic patients.

[1]  T. Yoshikawa,et al.  Adiponectin gene polymorphism (G276T) and diabetic retinopathy in Japanese patients with Type 2 diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[2]  T. Yoshikawa,et al.  Glimepiride and serum adiponectin level in type 2 diabetic subjects: response to Nagasaka et al. , 2003, Diabetes care.

[3]  J. Gross,et al.  The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes. , 2003, Diabetes.

[4]  V. Tesar,et al.  Genetics of diabetic nephropathy. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  R. Elston.  Genetic determinants of diabetic nephropathy: The family investigation of nephropathy and diabetes (FIND). , 2003, Journal of the American Society of Nephrology : JASN.

[6]  Toshio Hayashi,et al.  Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects. , 2003, Diabetes care.

[7]  H. Izawa,et al.  Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. , 2002, The New England journal of medicine.

[8]  T. Saruta,et al.  PPAR(gamma)2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population. , 2002, Metabolism: clinical and experimental.

[9]  R. A. Norman,et al.  The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. , 2002, Diabetes.

[10]  M. Stumvoll,et al.  Adiponectin--its role in metabolism and beyond. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[11]  J. Staessen,et al.  Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. , 2002, Diabetes.

[12]  T. Saruta,et al.  Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. , 2002, Metabolism: clinical and experimental.

[13]  C. Dina,et al.  Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. , 2002, Diabetes.

[14]  L. Groop,et al.  The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes , 2001, Diabetologia.

[15]  T. Nakamura,et al.  Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[16]  K. Tokuyama,et al.  Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. , 2000, Diabetes care.

[17]  T. Chowdhury,et al.  Genetic determinants of diabetic nephropathy. , 1999, Clinical science.

[18]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[19]  Y. Nakatani,et al.  Effect of Troglitazene on Microalbuminuria in Patients With Incipient Diabetic Nephropathy , 1998, Diabetes Care.

[20]  Johan Auwerx,et al.  A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity , 1998, Nature Genetics.

[21]  R. Hanson,et al.  Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. , 1998, Diabetes.

[22]  H. Kojima,et al.  Insulin resistance in diabetic microangiopathies. , 2000, Journal of diabetes and its complications.